Literature DB >> 1704016

T cell immunity and interferon-gamma secretion during experimental allergic encephalomyelitis in Lewis rats.

M I Mustafa1, P Diener, B Höjeberg, P Van der Meide, T Olsson.   

Abstract

An immunospot assay that detects single secretory cells was used to enumerate interferon-gamma secreting cells (IFN-gamma-sc) in mononuclear cell suspensions from the central nervous system (CNS) and peripheral lymphoid organs after actively induced experimental allergic encephalomyelitis (EAE) in Lewis rats. In the CNS compartment there was a significant increase in the number of IFN-gamma-sc preceding the onset of the clinical signs of EAE. Both in rats with EAE and rats immunized with Freund's complete adjuvant (FCA) the number of IFN-gamma-sc increased in peripheral lymphoid organs, as compared to non-immunized controls. In view of the potent immunoregulatory effects of IFN-gamma, its intra-CNS secretion may play a crucial role for clinicopathological events in EAE. To study the numbers of primed T cells that in response to myelin antigens produced IFN-gamma, mononuclear cell suspensions from peripheral lymphoid organs were precultured to allow for antigen uptake, presentation and T cell triggering, followed by enumeration of IFN-gamma-sc. T cells responding to a peptide of myelin basic protein (MBP) that previously have been shown encephalitogenic in Lewis rats, appeared initially and were quantitatively dominant over the course of EAE. Later, T cell reactivities to multiple regions of MBP appeared, showing that the concept of immunodominance in EAE is non-absolute and time dependent. Splenocyte cultures from EAE rats exposed to the different antigens showed a reduced number of IFN-gamma-sc compared to cultures not exposed to antigen, suggesting an antigen-induced suppression of T cell effector molecules.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704016     DOI: 10.1016/0165-5728(91)90022-y

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

1.  The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: implications for multiple sclerosis treatment.

Authors:  B Bourrié; E Bribes; M Esclangon; L Garcia; J Marchand; C Thomas; J P Maffrand; P Casellas
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 2.  Mechanisms of action of interferon-beta in multiple sclerosis.

Authors:  B G Arnason; A Dayal; Z X Qu; M A Jensen; K Genç; A T Reder
Journal:  Springer Semin Immunopathol       Date:  1996

3.  Differential levels of resistance to disease induction and development of relapsing experimental autoimmune encephalomyelitis in two H-2b-restricted mouse strains.

Authors:  Jinzhu Li; Xiaoqing Zhao; Robert Skoff; Michael K Shaw; Harley Y Tse
Journal:  J Neuroimmunol       Date:  2011-04-11       Impact factor: 3.478

Review 4.  Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis.

Authors:  R W Ledeen; G Chakraborty
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

5.  Potential role of autoantibodies in the regulation of cytokine responses during bacterial infections.

Authors:  M Bakhiet; A Diab; L Lindqvist; H Link
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Induction of the trypanosome lymphocyte-triggering factor (TLTF) and neutralizing antibodies to the TLTF in experimental african trypanosomiasis.

Authors:  M Hamadien; N Lycke; M Bakhiet
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

7.  Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.

Authors:  E Meinl; F Weber; K Drexler; C Morelle; M Ott; G Saruhan-Direskeneli; N Goebels; B Ertl; G Jechart; G Giegerich
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

8.  Myelin antigen reactive T cells in cerebrovascular diseases.

Authors:  W Z Wang; T Olsson; V Kostulas; B Höjeberg; H P Ekre; H Link
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

9.  Cellular mRNA expression of interferon-gamma, IL-4 and transforming growth factor-beta (TGF-beta) by rat mononuclear cells stimulated with peripheral nerve myelin antigens in experimental allergic neuritis.

Authors:  J Zhu; E Mix; T Olsson; H Link
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

10.  TLTF in cerebrospinal fluid for detection and staging of T. b. gambiense infection.

Authors:  Maha-Hamadien Abdulla; Moiz Bakhiet; Veerle Lejon; Jan Andersson; James McKerrow; Omar Al-Obeed; Robert A Harris
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.